AAAAAA
Results: 1-25/26
Authors:
BERTRAM J
PALFNER K
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., OVEREXPRESSION OF RIBOSOMAL-PROTEINS L4 AND L5 AND THE PUTATIVE ALTERNATIVE ELONGATION-FACTOR PTI-1 IN THE DOXORUBICIN-RESISTANT HUMAN COLON-CANCER CELL-LINE LOVODX(R), European journal of cancer, 34(5), 1998, pp. 731-736
Authors:
BERTRAM J
PALFNER K
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., ELEVATED EXPRESSION OF S100P, CAPL AND MAGE-3 IN DOXORUBICIN-RESISTANT CELL-LINES - COMPARISON OF MESSENGER-RNA DIFFERENTIAL DISPLAY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION AND SUBTRACTIVE SUPPRESSIVE HYBRIDIZATION FOR THE ANALYSIS OF DIFFERENTIAL GENE-EXPRESSION, Anti-cancer drugs, 9(4), 1998, pp. 311-317
Authors:
STRUTZ F
WIENEKE U
BRAESS J
KABOTH U
KNEBA M
RUMPF KW
GRUPP C
MULLER GA
Citation: F. Strutz et al., TREATMENT OF RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA WITH CYCLOPHOSPHAMIDE PULSE THERAPY, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1320-1321
Authors:
BRUHN T
HIDDEMANN W
KNEBA M
BERTRAM J
Citation: T. Bruhn et al., HAMMERHEAD RIBOZYMES TO REDUCE THYMIDYLATE SYNTHASE OVEREXPRESSION, Annals of oncology, 9, 1998, pp. 585-585
Authors:
POTT C
TIEMANN M
LINKE B
OTT MM
VONHOFEN M
BOLZ I
HIDDEMANN W
PARWARESCH R
KNEBA M
Citation: C. Pott et al., STRUCTURE OF BCL-1 AND IGH-CDR3 REARRANGEMENTS AS CLONAL MARKERS IN MANTLE CELL LYMPHOMAS, Leukemia, 12(10), 1998, pp. 1630-1637
Authors:
BERTRAM J
PALFNER K
POTT C
VEHMEYER K
HIDDEMANN W
SPROAT B
KNEBA M
Citation: J. Bertram et al., DEVELOPMENT OF RIBOZYMES AND ANTISENSE OLIGONUCLEOTIDES TARGETING GENES INVOLVED IN DRUG-RESISTANCE AND PATHOGENESIS OF B-CELL LYMPHOMA, European journal of cancer, 33, 1997, pp. 125-125
Authors:
LINKE B
BOLZ I
FAYYAZI A
VONHOFEN M
POTT C
BERTRAM J
HIDDEMANN W
KNEBA M
Citation: B. Linke et al., AUTOMATED HIGH-RESOLUTION PCR FRAGMENT ANALYSIS FOR IDENTIFICATION OFCLONALLY REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN GENES, Leukemia, 11(7), 1997, pp. 1055-1062
Authors:
BERTRAM J
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., EVIDENCE FOR A NATURALLY-OCCURRING BCL-2 ANTISENSE TRANSCRIPT WHICH IS NOT RESTRICTED TO THE T(14 18) TRANSLOCATION/, Blood, 90(10), 1997, pp. 3620-3620
Authors:
VONHOFEN M
BOLZ I
HIDDEMANN W
KNEBA M
Citation: M. Vonhofen et al., PROSPECTIVE MOLECULAR-GENETIC MONITORING OF HIGH-GRADE B-CELL LYMPHOMA BY POLYMERASE CHAIN-REACTION (IGH-CDR3), Blood, 90(10), 1997, pp. 3963-3963
Authors:
DROESE J
BOLZ I
BRUGGEMANN M
HIDDEMANN W
KNEBA M
Citation: J. Droese et al., IDENTIFICATION OF MONOCLONAL IGH- AND T-CELL RECEPTOR JUNCTIONS AND QUANTITATIVE DETECTION OF RESIDUAL DISEASE IN ALL BY PCR-GENE SCANNING, Blood, 90(10), 1997, pp. 812-812
Authors:
BERTRAM J
PALFNER K
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., INCREASE OF P-GLYCOPROTEIN-MEDIATED DRUG-RESISTANCE BY HSP 90-BETA, Anti-cancer drugs, 7(8), 1996, pp. 838-845
Authors:
BERTRAM J
PALFNER K
KILLIAN M
BRYSCH W
SCHLINGENSIEPEN KH
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., REVERSAL OF MULTIPLE-DRUG RESISTANCE IN-VITRO BY PHOSPHORATHIOATE OLIGONUCLEOTIDES AND RIBOZYMES, Anti-cancer drugs, 6(1), 1995, pp. 124-134
Authors:
LINKE B
PYTTLICH J
TIEMANN M
SUTTORP M
PARWARESCH R
HIDDEMANN W
KNEBA M
Citation: B. Linke et al., IDENTIFICATION AND STRUCTURAL-ANALYSIS OF REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN GENES IN LYMPHOMAS AND LEUKEMIAS, Leukemia, 9(5), 1995, pp. 840-847
Authors:
OTT MM
OTT G
ROBLICK U
LINKE B
KNEBA M
DELEON F
MULLERHERMELINK HK
Citation: Mm. Ott et al., LOCALIZED GASTRIC NON-HODGKINS-LYMPHOMA OF HIGH-GRADE MALIGNANCY IN PATIENTS WITH PREEXISTING CHRONIC LYMPHOCYTIC-LEUKEMIA OR IMMUNOCYTOMA, Leukemia, 9(4), 1995, pp. 609-614
Authors:
LINKE B
BOLZ I
POTT C
HIDDEMANN W
KNEBA M
Citation: B. Linke et al., USE OF UITMA DNA-POLYMERASE IMPROVES THE PCR DETECTION OF REARRANGED IMMUNOGLOBULIN HEAVY-CHAIN CDR3 JUNCTIONS, Leukemia, 9(12), 1995, pp. 2133-2137
Authors:
PALFNER K
KNEBA M
HIDDEMANN W
BERTRAM J
Citation: K. Palfner et al., QUANTIFICATION OF RIBOZYME-MEDIATED RNA CLEAVAGE USING SILVER-STAINEDPOLYACRYLAMIDE GELS, BioTechniques, 19(6), 1995, pp. 926-929
Authors:
PALFNER K
KNEBA M
HIDDEMANN W
BERTRAM J
Citation: K. Palfner et al., IMPROVEMENT OF HAMMERHEAD RIBOZYMES CLEAVING MDR-L MESSENGER-RNA, Biological chemistry Hoppe-Seyler, 376(5), 1995, pp. 289-295
Authors:
KNEBA M
EICK S
HERBST H
POTT C
BOLZ I
DALLENBACH F
HIDDEMANN W
STEIN H
Citation: M. Kneba et al., LOW INCIDENCE OF MBR BCL-2 J(H) FUSION GENES IN HODGKINS-DISEASE/, Journal of pathology, 175(4), 1995, pp. 381-389
Authors:
OTTMANN OG
HOELZER D
GRACIEN E
GANSER A
KELLY K
REUTZEL R
LIPP T
BUSCH FW
SCHWONZEN M
HEIL G
WANDT H
KOCH P
KOLBE K
HEYLL A
BENTZ M
PETERS S
DIEDRICH H
DETHLING J
MEYER P
NOWROUSIAN MR
LOFFLER B
WEISS A
KNEBA M
FOLLER A
GRAF M
HECHT T
Citation: Og. Ottmann et al., CONCOMITANT GRANULOCYTE-COLONY-STIMULATING FACTOR AND INDUCTION CHEMORADIOTHERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III TRIAL, Blood, 86(2), 1995, pp. 444-450
Authors:
BERTRAM J
PALFNER K
STADLER H
HIDDEMANN W
KNEBA M
Citation: J. Bertram et al., DEVELOPMENT OF ANTI THYMIDYLATE SYNTHASE AND ANTI MDR-1 RIBOZYMES TO IMPROVE CYTOTOXIC CHEMOTHERAPY, Blood, 86(10), 1995, pp. 2887-2887
Authors:
KNEBA M
BOLZ I
LINKE B
HIDDEMANN W
Citation: M. Kneba et al., ANALYSIS OF REARRANGED T-CELL RECEPTOR BETA-CHAIN GENES BY POLYMERASECHAIN-REACTION (PCR) DNA-SEQUENCING AND AUTOMATED HIGH-RESOLUTION PCRFRAGMENT ANALYSIS, Blood, 86(10), 1995, pp. 3930-3937
Authors:
KNEBA M
BOLZ I
LINKE B
BERTRAM J
ROTHAUPT D
HIDDEMANN W
Citation: M. Kneba et al., CHARACTERIZATION OF CLONE-SPECIFIC REARRANGED T-CELL RECEPTOR GAMMA-CHAIN GENES IN LYMPHOMAS AND LEUKEMIAS BY THE POLYMERASE CHAIN-REACTIONAND DNA-SEQUENCING, Blood, 84(2), 1994, pp. 574-581
Authors:
KNEBA M
LINKE B
BOLZ I
POTT C
ROTHAUPT D
HIDDEMANN W
Citation: M. Kneba et al., A NOVEL PCR-BASED TECHNIQUE FOR IDENTIFICATION OF CLONALLY REARRANGEDIMMUNOGLOBULIN HEAVY CHAIN-CELL AND T-CELL ANTIGEN RECEPTOR GENES IN LYMPHOMAS AND LEUKEMIAS, Blood, 84(10), 1994, pp. 10000442-10000442
Authors:
BERTRAM J
KILLIAN M
BRYSCH W
SCHLINGENSIEPEN KH
KNEBA M
Citation: J. Bertram et al., REDUCTION OF ERBB2 GENE-PRODUCT IN MAMMA CARCINOMA CELL-LINES BY ERBB2 MESSENGER-RNA-SPECIFIC AND TYROSINE KINASE CONSENSUS PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES, Biochemical and biophysical research communications, 200(1), 1994, pp. 661-667
Authors:
BOKEMEYER C
SCHMOLL HJ
HARSTRICK A
ILLIGER HJ
METZNER B
RATH U
HOHNLOSER J
CLEMM C
BERDEL W
SIEGERT W
RUTHER U
OSTERMANN H
KNEBA M
HARTLAPP JH
SCHRODER M
POLIWODA H
Citation: C. Bokemeyer et al., A PHASE I II STUDY OF A STEPWISE DOSE-ESCALATED REGIMEN OF CISPLATIN,ETOPOSIDE AND IFOSFAMIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED GERM-CELL TUMORS/, European journal of cancer, 29A(16), 1993, pp. 2225-2231